Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
Chen, H.-M., Ma, G., Gildener-Leapman, N., Eisenstein, S., Coakley, B. A., Ozao, J., Mandeli, J., Divino, C., Schwartz, M., Sung, M., Ferris, R., Kao, J., Wang, L.-H., Pan, P.-Y., Ko, E. C., Chen, S.-Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-14-2742
Date:
April, 2015
File:
PDF, 1.34 MB
english, 2015
File converter
More search results
More benefits 
